Abstract
Abstract

Background
Despite integrin being highlighted as a stiffness‐sensor molecule in matrix stiffness‐driven angiogenesis, other stiffness‐sensor molecules and their mechanosensory pathways related to angiogenesis in hepatocellular carcinoma (HCC) remain obscure. Here, we explored the interplay between Piezo1 and integrin β1 in the mechanosensory pathway and their effects on HCC angiogenesis to better understand matrix stiffness‐induced angiogenesis.


Methods

The role of Piezo1 in matrix stiffness‐induced angiogenesis was investigated using orthotopic liver cancer SD rat models with high liver stiffness background, and its clinical significance was evaluated in human HCC tissues. Matrix stiffness‐mediated Piezo1 upregulation and activation were assayed using an in vitro fibronectin (FN)‐coated cell culture system with different stiffness, Western blotting and Ca
2+
probe. The effects of shPiezo1‐conditioned medium (CM) on angiogenesis were examined by tube formation assay, wound healing assay and angiogenesis array. The underlying mechanism by which Piezo1 participated in matrix stiffness‐induced angiogenesis was analyzed by microRNA quantitative real‐time polymerase chain reaction (qRT‐PCR), matrix stiffness measurement, dual‐luciferase reporter assay, ubiquitination assay and co‐immunoprecipitation.



Results
Increased matrix stiffness significantly upregulated Piezo1 expression at both cellular and tissue levels, and high expression of Piezo1 indicated an unfavorable prognosis. High matrix stiffness also noticeably enhanced the activation level of Piezo1, similar to its expression level. Piezo1 knockdown significantly suppressed tumor growth, angiogenesis, and lung metastasis of HCC rat models with high liver stiffness background. shPiezo1‐CM from HCC cells attenuated tube formation and migration abilities of vascular endothelial cells remarkably, and analysis of differentially expressed pro‐angiogenic factors revealed that Piezo1 promoted the expression and secretion of vascular endothelial growth factor (VEGF), CXC chemokine ligand 16 (CXCL16) and insulin‐like growth factor binding protein 2 (IGFBP2). Matrix stiffness‐caused Piezo1 upregulation/activation restrained hypoxia inducible factor‐1α (HIF‐1α) ubiquitination, subsequently enhanced the expression of downstream pro‐angiogenic factors to accelerate HCC angiogenesis. Besides, collagen 1 (COL1)‐reinforced tissue stiffening resulted in more expression of Piezo1 via miR‐625‐5p.


Conclusions

This study unravels a new mechanism by which the integrin β1/Piezo1 activation/Ca
2+
influx/HIF‐1α ubiquitination/VEGF, CXCL16 and IGFBP2 pathway participates in matrix stiffness‐driven HCC angiogenesis. Simultaneously, a positive feedback regulation loop as stiff matrix/integrin β1/miR‐625‐5p/Piezo1 and COL1/stiffer matrix mediates matrix stiffness‐caused Piezo1 upregulation.
Topics

No keywords indexed for this article. Browse by subject →

References
68
[1]
Fidler IJ. Angiogenesis and cancer metastasis. Cancer J. 2000;6 Suppl 2:S134‐41.
[3]
Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 2006;242((2)):151‐67. 10.1016/j.canlet.2006.01.008
[4]
Wang YH, Dong YY, Wang WM, Xie XY, Wang ZM, Chen RX, et al. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF‐κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013;32((1)):51. 10.1186/1756-9966-32-51
[6]
Rizzo A, Dadduzio V, Ricci AD, Massari F, Di Federico A, Gadaleta‐Caldarola G, et al. Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma? Expert Opin Investig Drugs. 2022;31((4)):371‐8. 10.1080/13543784.2021.1948532
[9]
Huang A, Yang XR, Chung WY, Dennison AR, Zhou J. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5((1)):146. 10.1038/s41392-020-00264-x
[14]
Mechanism and its regulation of tumor-induced angiogenesis

Manoj Kumar Gupta

World Journal of Gastroenterology 10.3748/wjg.v9.i6.1144
[15]
Krock BL, Skuli N, Simon MC. Hypoxia‐induced angiogenesis: good and evil. Genes Cancer. 2011;2((12)):1117‐33. 10.1177/1947601911423654
[18]
Dong Y, Zheng Q, Wang Z, Lin X, You Y, Wu S, et al. Higher matrix stiffness as an independent initiator triggers epithelial‐mesenchymal transition and facilitates HCC metastasis. J Hematol Oncol. 2019;12((1)):112. 10.1186/s13045-019-0795-5
[20]
Wu S, Zheng Q, Xing X, Dong Y, Wang Y, You Y, et al. Matrix stiffness‐upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre‐metastatic niche formation. J Exp Clin Cancer Res. 2018;37((1)):99. 10.1186/s13046-018-0761-z
[21]
Wu S, Xing X, Wang Y, Zhang X, Li M, Wang M, et al. The pathological significance of LOXL2 in pre‐metastatic niche formation of HCC and its related molecular mechanism. Eur J Cancer. 2021;147:63‐73. 10.1016/j.ejca.2021.01.011
[23]
Zhao W, Lv M, Yang X, Zhou J, Xing B, Zhang Z. Liver tumor‐initiating cells initiate the formation of a stiff cancer stem cell microenvironment niche by secreting LOX. Carcinogenesis. 2022 Apr 18:bgac035. 10.1093/carcin/bgac035
[24]
You Y, Zheng Q, Dong Y, Wang Y, Zhang L, Xue T, et al. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β‐Catenin Signaling Pathway. PLoS One. 2015;10((8)):e0134243. 10.1371/journal.pone.0134243
[25]
Yang N, Chen T, Wang L, Liu R, Niu Y, Sun L, et al. CXCR4 mediates matrix stiffness‐induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. Theranostics. 2020;10((13)):5790‐801. 10.7150/thno.44789
[27]
Liu QP, Luo Q, Deng B, Ju Y, Song GB. Stiffer Matrix Accelerates Migration of Hepatocellular Carcinoma Cells through Enhanced Aerobic Glycolysis Via the MAPK‐YAP Signaling. Cancers (Basel). 2020;12((2)).
[28]
Filliol A, Schwabe RF. Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis. Semin Liver Dis. 2019;39((3)):315‐33. 10.1055/s-0039-1685539
[30]
Gao X, Qiao X, Xing X, Huang J, Qian J, Wang Y, et al. Matrix Stiffness‐Upregulated MicroRNA‐17‐5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway. Front Oncol. 2020;10:1563. 10.3389/fonc.2020.01563
[31]
Dong Y, Xie X, Wang Z, Hu C, Zheng Q, Wang Y, et al. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1. Biochem Biophys Res Commun. 2014;444((3)):427‐32. 10.1016/j.bbrc.2014.01.079
[32]
Wang Y, Zhang X, Wang W, Xing X, Wu S, Dong Y, et al. Integrin αVβ5/Akt/Sp1 pathway participates in matrix stiffness‐mediated effects on VEGFR2 upregulation in vascular endothelial cells. Am J Cancer Res. 2020;10((8)):2635‐48.
[36]
Tsuchiya M, Hara Y, Okuda M, Itoh K, Nishioka R, Shiomi A, et al. Cell surface flip‐flop of phosphatidylserine is critical for PIEZO1‐mediated myotube formation. Nat Commun. 2018;9((1)):2049. 10.1038/s41467-018-04436-w
[39]
Kang H, Hong Z, Zhong M, Klomp J, Bayless KJ, Mehta D, et al. Piezo1 mediates angiogenesis through activation of MT1‐MMP signaling. Am J Physiol Cell Physiol. 2019;316((1)):C92‐c103. 10.1152/ajpcell.00346.2018
[40]
Wang TH, Hsia SM, Shieh TM. Lysyl Oxidase and the Tumor Microenvironment. Int J Mol Sci. 2016;18((1)).
[41]
Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17((1)):309. 10.1186/s12967-019-2058-1
[43]
Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10((2) Suppl 1):S115‐20. 10.1002/lt.20034
[44]
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67((2)):93‐9.
[46]
Agbim U, Asrani SK. Non‐invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol. 2019;13((4)):361‐74. 10.1080/17474124.2019.1579641
[47]
Terada H, Komeichi H, Aramaki T. [Child‐Pugh classification in liver cirrhosis]. Ryoikibetsu Shokogun Shirizu. 1995((7)):151‐4.
[48]
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24((2)):289‐93. 10.1002/hep.510240201
[49]
EASL‐ALEH Clinical Practice Guidelines : Non‐invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63((1)):237‐64. 10.1016/j.jhep.2015.04.006
[50]
Sullivan R, Maresh G, Zhang X, Salomon C, Hooper J, Margolin D, et al. The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond. Front Endocrinol (Lausanne). 2017;8:194. 10.3389/fendo.2017.00194

Showing 50 of 68 references

Metrics
137
Citations
68
References
Details
Published
Oct 01, 2022
Vol/Issue
42(11)
Pages
1162-1184
License
View
Authors
Funding
National Natural Science Foundation of China Award: 81972910
Cite This Article
Miao Li, Xi Zhang, Mimi Wang, et al. (2022). Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma. Cancer Communications, 42(11), 1162-1184. https://doi.org/10.1002/cac2.12364